APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Finasteride Tablet

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Finasteride Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchOral Finasteride Tablet Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Finasteride Tablet Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Oral Finasteride Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Finasteride Tablet Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Finasteride Tablet Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Oral Finasteride Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Finasteride Tablet include Zhejiang Xianju Pharmaceutical Co., Ltd, Tianfang Pharmaceutical Co., Ltd, Shanghai Xinya Pharmaceutical Minhang Co., Ltd, Shanghai Hyundai Pharmaceutical Co., Ltd, Sandoz, Renhetang Pharmaceutical Company Limited, Nanjing Shenghe Pharmaceutical Co., Ltd, Nanjing Sea Whale Pharmaceutical Co., Ltd and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Finasteride Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Finasteride Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Finasteride Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Finasteride Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Finasteride Tablet Segment by Company

Zhejiang Xianju Pharmaceutical Co., Ltd

Tianfang Pharmaceutical Co., Ltd

Shanghai Xinya Pharmaceutical Minhang Co., Ltd

Shanghai Hyundai Pharmaceutical Co., Ltd

Sandoz

Renhetang Pharmaceutical Company Limited

Nanjing Shenghe Pharmaceutical Co., Ltd

Nanjing Sea Whale Pharmaceutical Co., Ltd

Merck

Runenberg Pharmaceuticals Ltd

CR SECCO Pharmaceutical Co., Ltd

Hunan Zhengqing Pharmaceutical Group Co., Ltd

Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd

Hunan Baicao Pharmaceutical Co., Ltd

Hangzhou Kangenbei Pharmaceutical Co., Ltd

Guangdong Yishu Pharmaceutical Co., Ltd

RelonChem

Dr. Reddy

Cipla

Actavis

Accord Pharmaceuticals

Oral Finasteride Tablet Segment by Type

1mg

5mg

Oral Finasteride Tablet Segment by Application

Urology

Dermatology

Oral Finasteride Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Finasteride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Finasteride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Finasteride Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Finasteride Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Finasteride Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Finasteride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Finasteride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Finasteride Tablet Industry Trends Table 2. Oral Finasteride Tablet Industry Drivers Table 3. Oral Finasteride Tablet Industry Opportunities and Challenges Table 4. Oral Finasteride Tablet Industry Restraints Table 5. Global Oral Finasteride Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Finasteride Tablet Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Finasteride Tablet Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oral Finasteride Tablet Sales Market Share by Manufacturers Table 9. Global Oral Finasteride Tablet Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oral Finasteride Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Finasteride Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Finasteride Tablet Manufacturers, Product Type & Application Table 13. Global Oral Finasteride Tablet Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Finasteride Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1mg Table 17. Major Manufacturers of 5mg Table 18. Global Oral Finasteride Tablet Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 20. Global Oral Finasteride Tablet Sales by Type (2027-2032) & (K Units) Table 21. Global Oral Finasteride Tablet Sales Market Share by Type (2021-2026) Table 22. Global Oral Finasteride Tablet Sales Market Share by Type (2027-2032) Table 23. Global Oral Finasteride Tablet Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Oral Finasteride Tablet Revenue by Type (2021-2026) & (K Units) Table 25. Global Oral Finasteride Tablet Revenue by Type (2027-2032) & (K Units) Table 26. Global Oral Finasteride Tablet Revenue Market Share by Type (2021-2026) Table 27. Global Oral Finasteride Tablet Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Urology Table 29. Major Manufacturers of Dermatology Table 30. Global Oral Finasteride Tablet Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 32. Global Oral Finasteride Tablet Sales by Application (2027-2032) & (K Units) Table 33. Global Oral Finasteride Tablet Sales Market Share by Application (2021-2026) Table 34. Global Oral Finasteride Tablet Sales Market Share by Application (2027-2032) Table 35. Global Oral Finasteride Tablet Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Oral Finasteride Tablet Revenue by Application (2021-2026) & (K Units) Table 37. Global Oral Finasteride Tablet Revenue by Application (2027-2032) & (K Units) Table 38. Global Oral Finasteride Tablet Revenue Market Share by Application (2021-2026) Table 39. Global Oral Finasteride Tablet Revenue Market Share by Application (2027-2032) Table 40. Global Oral Finasteride Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Oral Finasteride Tablet Sales by Region (2021-2026) & (K Units) Table 42. Global Oral Finasteride Tablet Sales Market Share by Region (2021-2026) Table 43. Global Oral Finasteride Tablet Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Oral Finasteride Tablet Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Oral Finasteride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 47. North America Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 48. Europe Oral Finasteride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 50. Europe Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Oral Finasteride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Oral Finasteride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 57. Global Oral Finasteride Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Oral Finasteride Tablet Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Oral Finasteride Tablet Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Oral Finasteride Tablet Revenue Market Share by Region (2021-2026) Table 61. Global Oral Finasteride Tablet Revenue Market Share by Region (2027-2032) Table 62. Zhejiang Xianju Pharmaceutical Co., Ltd Company Information Table 63. Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview Table 64. Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 66. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Development Table 67. Tianfang Pharmaceutical Co., Ltd Company Information Table 68. Tianfang Pharmaceutical Co., Ltd Business Overview Table 69. Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 71. Tianfang Pharmaceutical Co., Ltd Recent Development Table 72. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information Table 73. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview Table 74. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Portfolio Table 76. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Development Table 77. Shanghai Hyundai Pharmaceutical Co., Ltd Company Information Table 78. Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview Table 79. Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 81. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Development Table 82. Sandoz Company Information Table 83. Sandoz Business Overview Table 84. Sandoz Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sandoz Oral Finasteride Tablet Product Portfolio Table 86. Sandoz Recent Development Table 87. Renhetang Pharmaceutical Company Limited Company Information Table 88. Renhetang Pharmaceutical Company Limited Business Overview Table 89. Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Portfolio Table 91. Renhetang Pharmaceutical Company Limited Recent Development Table 92. Nanjing Shenghe Pharmaceutical Co., Ltd Company Information Table 93. Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview Table 94. Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 96. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Development Table 97. Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information Table 98. Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview Table 99. Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 101. Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Development Table 102. Merck Company Information Table 103. Merck Business Overview Table 104. Merck Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Merck Oral Finasteride Tablet Product Portfolio Table 106. Merck Recent Development Table 107. Runenberg Pharmaceuticals Ltd Company Information Table 108. Runenberg Pharmaceuticals Ltd Business Overview Table 109. Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Portfolio Table 111. Runenberg Pharmaceuticals Ltd Recent Development Table 112. CR SECCO Pharmaceutical Co., Ltd Company Information Table 113. CR SECCO Pharmaceutical Co., Ltd Business Overview Table 114. CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 116. CR SECCO Pharmaceutical Co., Ltd Recent Development Table 117. Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information Table 118. Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview Table 119. Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Portfolio Table 121. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Development Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 126. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Development Table 127. Hunan Baicao Pharmaceutical Co., Ltd Company Information Table 128. Hunan Baicao Pharmaceutical Co., Ltd Business Overview Table 129. Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 131. Hunan Baicao Pharmaceutical Co., Ltd Recent Development Table 132. Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information Table 133. Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview Table 134. Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 136. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Development Table 137. Guangdong Yishu Pharmaceutical Co., Ltd Company Information Table 138. Guangdong Yishu Pharmaceutical Co., Ltd Business Overview Table 139. Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 141. Guangdong Yishu Pharmaceutical Co., Ltd Recent Development Table 142. RelonChem Company Information Table 143. RelonChem Business Overview Table 144. RelonChem Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. RelonChem Oral Finasteride Tablet Product Portfolio Table 146. RelonChem Recent Development Table 147. Dr. Reddy Company Information Table 148. Dr. Reddy Business Overview Table 149. Dr. Reddy Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Dr. Reddy Oral Finasteride Tablet Product Portfolio Table 151. Dr. Reddy Recent Development Table 152. Cipla Company Information Table 153. Cipla Business Overview Table 154. Cipla Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Cipla Oral Finasteride Tablet Product Portfolio Table 156. Cipla Recent Development Table 157. Actavis Company Information Table 158. Actavis Business Overview Table 159. Actavis Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Actavis Oral Finasteride Tablet Product Portfolio Table 161. Actavis Recent Development Table 162. Accord Pharmaceuticals Company Information Table 163. Accord Pharmaceuticals Business Overview Table 164. Accord Pharmaceuticals Oral Finasteride Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Accord Pharmaceuticals Oral Finasteride Tablet Product Portfolio Table 166. Accord Pharmaceuticals Recent Development Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Oral Finasteride Tablet Distributors List Table 170. Oral Finasteride Tablet Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Oral Finasteride Tablet Product Image Figure 2. Global Oral Finasteride Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Finasteride Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Finasteride Tablet Sales (2021-2032) & (K Units) Figure 5. Global Oral Finasteride Tablet Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Finasteride Tablet Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1mg Image Figure 9. 5mg Image Figure 10. Global Oral Finasteride Tablet Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Oral Finasteride Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Oral Finasteride Tablet Sales Market Share by Type (2021-2032) Figure 13. Global Oral Finasteride Tablet Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Oral Finasteride Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oral Finasteride Tablet Revenue Market Share by Type (2021-2032) Figure 16. Urology Image Figure 17. Dermatology Image Figure 18. Global Oral Finasteride Tablet Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Oral Finasteride Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Oral Finasteride Tablet Sales Market Share by Application (2021-2032) Figure 21. Global Oral Finasteride Tablet Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Oral Finasteride Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Oral Finasteride Tablet Revenue Market Share by Application (2021-2032) Figure 24. North America Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Oral Finasteride Tablet Sales Market Share by Country (2021-2032) Figure 26. U.S. Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Oral Finasteride Tablet Sales Market Share by Country (2021-2032) Figure 31. Germany Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Oral Finasteride Tablet Sales Market Share by Country (2021-2032) Figure 38. China Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Oral Finasteride Tablet Sales Market Share by Country (2021-2032) Figure 46. Brazil Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Oral Finasteride Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Oral Finasteride Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Oral Finasteride Tablet Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Figure 57. North America Oral Finasteride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Figure 59. Europe Oral Finasteride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Oral Finasteride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Oral Finasteride Tablet Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Oral Finasteride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Oral Finasteride Tablet Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Oral Finasteride Tablet Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 5mg
Applications
  • Urology
  • Dermatology
Companies covered
  • Zhejiang Xianju Pharmaceutical Co., Ltd
  • Tianfang Pharmaceutical Co., Ltd
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd
  • Shanghai Hyundai Pharmaceutical Co., Ltd
  • Sandoz
  • Renhetang Pharmaceutical Company Limited
  • Nanjing Shenghe Pharmaceutical Co., Ltd
  • Nanjing Sea Whale Pharmaceutical Co., Ltd
  • Merck
  • Runenberg Pharmaceuticals Ltd
  • CR SECCO Pharmaceutical Co., Ltd
  • Hunan Zhengqing Pharmaceutical Group Co., Ltd
  • Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
  • Hunan Baicao Pharmaceutical Co., Ltd
  • Hangzhou Kangenbei Pharmaceutical Co., Ltd
  • Guangdong Yishu Pharmaceutical Co., Ltd
  • RelonChem
  • Dr. Reddy
  • Cipla
  • Actavis
  • Accord Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Finasteride Tablet Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Finasteride Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Finasteride Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Finasteride Tablet Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Finasteride Tablet Market Dynamics
  1. 2.1 Oral Finasteride Tablet Industry Trends
  2. 2.2 Oral Finasteride Tablet Industry Drivers
  3. 2.3 Oral Finasteride Tablet Industry Opportunities and Challenges
  4. 2.4 Oral Finasteride Tablet Industry Restraints
3 Oral Finasteride Tablet Market by Manufacturers
  1. 3.1 Global Oral Finasteride Tablet Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Finasteride Tablet Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Finasteride Tablet Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Finasteride Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Finasteride Tablet Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Finasteride Tablet Manufacturers, Product Type & Application
  7. 3.7 Global Oral Finasteride Tablet Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Finasteride Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Finasteride Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Finasteride Tablet Tier 1, Tier 2, and Tier 3
4 Oral Finasteride Tablet Market by Type
  1. 4.1 Oral Finasteride Tablet Type Introduction
  2. 4.1.1 1mg
  3. 4.1.2 5mg
  4. 4.2 Global Oral Finasteride Tablet Sales by Type
  5. 4.2.1 Global Oral Finasteride Tablet Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral Finasteride Tablet Sales by Type (2021-2032)
  7. 4.2.3 Global Oral Finasteride Tablet Sales Market Share by Type (2021-2032)
  8. 4.3 Global Oral Finasteride Tablet Revenue by Type
  9. 4.3.1 Global Oral Finasteride Tablet Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral Finasteride Tablet Revenue by Type (2021-2032)
  11. 4.3.3 Global Oral Finasteride Tablet Revenue Market Share by Type (2021-2032)
5 Oral Finasteride Tablet Market by Application
  1. 5.1 Oral Finasteride Tablet Application Introduction
  2. 5.1.1 Urology
  3. 5.1.2 Dermatology
  4. 5.2 Global Oral Finasteride Tablet Sales by Application
  5. 5.2.1 Global Oral Finasteride Tablet Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Finasteride Tablet Sales by Application (2021-2032)
  7. 5.2.3 Global Oral Finasteride Tablet Sales Market Share by Application (2021-2032)
  8. 5.3 Global Oral Finasteride Tablet Revenue by Application
  9. 5.3.1 Global Oral Finasteride Tablet Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Finasteride Tablet Revenue by Application (2021-2032)
  11. 5.3.3 Global Oral Finasteride Tablet Revenue Market Share by Application (2021-2032)
6 Global Oral Finasteride Tablet Sales by Region
  1. 6.1 Global Oral Finasteride Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Finasteride Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Finasteride Tablet Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Finasteride Tablet Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Finasteride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Finasteride Tablet Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Finasteride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Finasteride Tablet Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Finasteride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Finasteride Tablet Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Finasteride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Finasteride Tablet Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Finasteride Tablet Revenue by Region
  1. 7.1 Global Oral Finasteride Tablet Revenue by Region
  2. 7.1.1 Global Oral Finasteride Tablet Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Finasteride Tablet Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Finasteride Tablet Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Finasteride Tablet Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Finasteride Tablet Revenue (2021-2032)
  8. 7.2.2 North America Oral Finasteride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Finasteride Tablet Revenue (2021-2032)
  11. 7.3.2 Europe Oral Finasteride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Finasteride Tablet Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Finasteride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Finasteride Tablet Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Finasteride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju Pharmaceutical Co., Ltd
  2. 8.1.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
  3. 8.1.2 Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview
  4. 8.1.3 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  6. 8.1.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments
  7. 8.2 Tianfang Pharmaceutical Co., Ltd
  8. 8.2.1 Tianfang Pharmaceutical Co., Ltd Company Information
  9. 8.2.2 Tianfang Pharmaceutical Co., Ltd Business Overview
  10. 8.2.3 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  12. 8.2.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
  13. 8.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
  14. 8.3.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information
  15. 8.3.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview
  16. 8.3.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Portfolio
  18. 8.3.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments
  19. 8.4 Shanghai Hyundai Pharmaceutical Co., Ltd
  20. 8.4.1 Shanghai Hyundai Pharmaceutical Co., Ltd Company Information
  21. 8.4.2 Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview
  22. 8.4.3 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  24. 8.4.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments
  25. 8.5 Sandoz
  26. 8.5.1 Sandoz Company Information
  27. 8.5.2 Sandoz Business Overview
  28. 8.5.3 Sandoz Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz Oral Finasteride Tablet Product Portfolio
  30. 8.5.5 Sandoz Recent Developments
  31. 8.6 Renhetang Pharmaceutical Company Limited
  32. 8.6.1 Renhetang Pharmaceutical Company Limited Company Information
  33. 8.6.2 Renhetang Pharmaceutical Company Limited Business Overview
  34. 8.6.3 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Portfolio
  36. 8.6.5 Renhetang Pharmaceutical Company Limited Recent Developments
  37. 8.7 Nanjing Shenghe Pharmaceutical Co., Ltd
  38. 8.7.1 Nanjing Shenghe Pharmaceutical Co., Ltd Company Information
  39. 8.7.2 Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview
  40. 8.7.3 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  42. 8.7.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments
  43. 8.8 Nanjing Sea Whale Pharmaceutical Co., Ltd
  44. 8.8.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information
  45. 8.8.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview
  46. 8.8.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  48. 8.8.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Oral Finasteride Tablet Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Runenberg Pharmaceuticals Ltd
  56. 8.10.1 Runenberg Pharmaceuticals Ltd Company Information
  57. 8.10.2 Runenberg Pharmaceuticals Ltd Business Overview
  58. 8.10.3 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Portfolio
  60. 8.10.5 Runenberg Pharmaceuticals Ltd Recent Developments
  61. 8.11 CR SECCO Pharmaceutical Co., Ltd
  62. 8.11.1 CR SECCO Pharmaceutical Co., Ltd Company Information
  63. 8.11.2 CR SECCO Pharmaceutical Co., Ltd Business Overview
  64. 8.11.3 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  66. 8.11.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments
  67. 8.12 Hunan Zhengqing Pharmaceutical Group Co., Ltd
  68. 8.12.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information
  69. 8.12.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview
  70. 8.12.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Portfolio
  72. 8.12.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments
  73. 8.13 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
  74. 8.13.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information
  75. 8.13.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview
  76. 8.13.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  78. 8.13.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments
  79. 8.14 Hunan Baicao Pharmaceutical Co., Ltd
  80. 8.14.1 Hunan Baicao Pharmaceutical Co., Ltd Company Information
  81. 8.14.2 Hunan Baicao Pharmaceutical Co., Ltd Business Overview
  82. 8.14.3 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  84. 8.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments
  85. 8.15 Hangzhou Kangenbei Pharmaceutical Co., Ltd
  86. 8.15.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information
  87. 8.15.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview
  88. 8.15.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  90. 8.15.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments
  91. 8.16 Guangdong Yishu Pharmaceutical Co., Ltd
  92. 8.16.1 Guangdong Yishu Pharmaceutical Co., Ltd Company Information
  93. 8.16.2 Guangdong Yishu Pharmaceutical Co., Ltd Business Overview
  94. 8.16.3 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  96. 8.16.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments
  97. 8.17 RelonChem
  98. 8.17.1 RelonChem Company Information
  99. 8.17.2 RelonChem Business Overview
  100. 8.17.3 RelonChem Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 RelonChem Oral Finasteride Tablet Product Portfolio
  102. 8.17.5 RelonChem Recent Developments
  103. 8.18 Dr. Reddy
  104. 8.18.1 Dr. Reddy Company Information
  105. 8.18.2 Dr. Reddy Business Overview
  106. 8.18.3 Dr. Reddy Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Dr. Reddy Oral Finasteride Tablet Product Portfolio
  108. 8.18.5 Dr. Reddy Recent Developments
  109. 8.19 Cipla
  110. 8.19.1 Cipla Company Information
  111. 8.19.2 Cipla Business Overview
  112. 8.19.3 Cipla Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Cipla Oral Finasteride Tablet Product Portfolio
  114. 8.19.5 Cipla Recent Developments
  115. 8.20 Actavis
  116. 8.20.1 Actavis Company Information
  117. 8.20.2 Actavis Business Overview
  118. 8.20.3 Actavis Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Actavis Oral Finasteride Tablet Product Portfolio
  120. 8.20.5 Actavis Recent Developments
  121. 8.21 Accord Pharmaceuticals
  122. 8.21.1 Accord Pharmaceuticals Company Information
  123. 8.21.2 Accord Pharmaceuticals Business Overview
  124. 8.21.3 Accord Pharmaceuticals Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Accord Pharmaceuticals Oral Finasteride Tablet Product Portfolio
  126. 8.21.5 Accord Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Finasteride Tablet Value Chain Analysis
  2. 9.1.1 Oral Finasteride Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Finasteride Tablet Production Mode & Process
  6. 9.2 Oral Finasteride Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Finasteride Tablet Distributors
  9. 9.2.3 Oral Finasteride Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst